Suppr超能文献

宠物主人对改善骨关节炎相关猫疼痛的生活质量及创新疗法成本的偏好——一项定量调查

Pet Owners' Preferences for Quality of Life Improvements and Costs Related to Innovative Therapies in Feline Pain Associated with Osteoarthritis-A Quantitative Survey.

作者信息

Wright Andrea, Gildea Edwina, Longstaff Louise, Riley Danielle, Nagda Nirav, DiPietrantonio Kristina, Enstone Ashley, Wyn Robin, Bartram David

机构信息

Zoetis, 10 Sylvan Way, Parsippany, NJ 07054, USA.

Zoetis UK Ltd., First Floor, Birchwood Building, Springfield Drive, Leatherhead KT22 7LP, UK.

出版信息

Animals (Basel). 2024 Aug 8;14(16):2308. doi: 10.3390/ani14162308.

Abstract

This research aimed to explore UK cat owners' preferences for treatments for feline osteoarthritis (OA) by exploring preferences around quality of life (QoL) improvements, safety considerations, and costs associated with hypothetical innovative pain therapies. Aspects identified in an existing conceptual framework were extracted for inclusion in exploratory interviews with cat owners ( = 3) to identify key domains that contribute to the QoL of cats. QoL descriptions for cats with OA and hypothetical product attributes were developed and validated through interviews with veterinarians ( = 3). An online survey was subsequently shared with 255 pet owners in the UK. Pet owners were presented with QoL descriptions and hypothetical product attributes to gather their preferences for QoL improvements and their willingness to pay (WTP) for (unbranded) pain therapies at various price points. Pet owners were motivated to improve their cats' QoL, which translated into WTP for therapies; specifically, pet owners valued QoL improvements in mobility, pain expression, and well-being. When presented with a product profile of the hypothetical novel monoclonal antibody (mAb) and cost, 50% of cat owners were willing to pay more for a mAb that is expected to have improved efficacy and safety when compared to a hypothetical standard of care (SoC). Significantly more pet owners preferred the mAb than the SoC when price was not presented ( < 0.01), with product efficacy and safety driving pet owners' decision-making. The majority of pet owners did not agree that taking their cats to the veterinarian once a month for their treatment would be burdensome. Cat owners in the UK are motivated to improve their cats' QoL, which translates into WTP for the efficacious treatment of pain associated with osteoarthritis. Veterinarians should offer cat owners the pain treatment they feel is best suited for improving the cat's QoL and to ensure subsequent owner-pet bond is preserved.

摘要

本研究旨在通过探讨围绕生活质量(QoL)改善、安全考量以及与假设的创新疼痛疗法相关的成本等方面的偏好,来探究英国养猫者对猫骨关节炎(OA)治疗方法的偏好。从现有的概念框架中提取相关方面,纳入对养猫者(n = 3)的探索性访谈中,以确定有助于猫生活质量的关键领域。通过与兽医(n = 3)的访谈,制定并验证了针对患OA猫的生活质量描述和假设的产品属性。随后,向英国的255名宠物主人进行了一项在线调查。向宠物主人展示生活质量描述和假设的产品属性,以收集他们对生活质量改善的偏好以及他们在不同价格点对(无品牌)疼痛疗法的支付意愿(WTP)。宠物主人有动力改善他们猫的生活质量,这转化为对疗法的支付意愿;具体而言,宠物主人重视在行动能力、疼痛表现和幸福感方面的生活质量改善。当呈现假设的新型单克隆抗体(mAb)的产品简介和成本时,50%的养猫者愿意为一种与假设的标准治疗(SoC)相比预期具有更高疗效和安全性的mAb支付更多费用。当不提及价格时,明显更多的宠物主人更喜欢mAb而非SoC(P < 0.01),产品疗效和安全性驱动着宠物主人的决策。大多数宠物主人不同意每月带他们的猫去看兽医进行治疗会很麻烦。英国的养猫者有动力改善他们猫的生活质量,这转化为对有效治疗与骨关节炎相关疼痛的支付意愿。兽医应该为养猫者提供他们认为最适合改善猫生活质量的疼痛治疗,并确保随后的主人 - 宠物关系得以维系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e105/11350694/b9a1d3bae147/animals-14-02308-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验